Reduction in psoriasis related pruritus during biologic therapy. - Suppr | 超能文献

Reduction in psoriasis related pruritus during biologic therapy.

作者信息

Lazzeri L, Pescitelli L, Tripo L, Ricceri F, Prignano F

机构信息

Department of Surgery and Translational Medicine - Section of Dermatology, University of Florence, Florence, Italy.

出版信息

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12442. Epub 2016 Nov 27.

DOI:10.1111/dth.12442

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Reduction in psoriasis related pruritus during biologic therapy.

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12442. Epub 2016 Nov 27.

2

Persistent pruritus in psoriatic patients during administration of biologics.银屑病患者在使用生物制剂期间持续存在瘙痒症状。

J Dermatol. 2018 Aug;45(8):e223. doi: 10.1111/1346-8138.14284. Epub 2018 Mar 6.

3

Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study.在日常皮肤科实际临床实践中，与银屑病生物治疗成功转换相关的因素：Resoswitch研究

Dermatol Ther. 2019 Mar;32(2):e12789. doi: 10.1111/dth.12789. Epub 2019 Jan 17.

4

Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.中度至重度银屑病生物治疗中的剂量调整：临床实践环境中的描述性分析

Actas Dermosifiliogr. 2015 Sep;106(7):569-77. doi: 10.1016/j.ad.2015.02.003. Epub 2015 Apr 30.

5

Biologic therapy in erythrodermic and pustular psoriasis.红皮病型和脓疱型银屑病的生物治疗

J Drugs Dermatol. 2014 Mar;13(3):342-54.

6

Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?生物疗法联合或不联合局部治疗在银屑病中的应用：现有证据说明了什么？

Am J Clin Dermatol. 2014 Oct;15(5):379-85. doi: 10.1007/s40257-014-0089-1.

7

Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.

J Drugs Dermatol. 2013 Dec;12(12):1456-60.

8

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.依那西普治疗银屑病患者报告的改善结果：一项随机III期试验的结果

Br J Dermatol. 2005 Dec;153(6):1192-9. doi: 10.1111/j.1365-2133.2005.06948.x.

9

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?生物制剂治疗银屑病的长期疗效：我们究竟了解多少？

Dermatol Ther. 2009 Sep-Oct;22(5):431-40. doi: 10.1111/j.1529-8019.2009.01259.x.

10

Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.卡泊三醇倍他米松二丙酸酯外用混悬液治疗寻常型银屑病的真实治疗情况

J Drugs Dermatol. 2014 Nov;13(11):1374-9.

引用本文的文献

1

Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies.司库奇尤单抗治疗对中度至重度斑块状银屑病患者瘙痒及银屑病面积和严重程度指数的影响：两项III期随机研究的综合分析

Dermatol Ther (Heidelb). 2018 Dec;8(4):621-637. doi: 10.1007/s13555-018-0267-9. Epub 2018 Nov 21.